Table 3.
Relative quantification of Toll-like receptors (TLRs) mRNA expression [control versus systemic lupus erythematosus (SLE) patients].
Control | SLE | P-value* | |
---|---|---|---|
TLR-2 | 0·082 ± 0·045 | 0·119 ± 0·058 | 0·019 |
TLR-3 | 1·801 ± 2·137 | 2·609 ± 2·069 | 0·089 |
TLR-4 | 3·035 ± 1·505 | 4·407 ± 2·239 | 0·051 |
TLR-5 | 0·243 ± 0·184 | 0·269 ± 0·132 | 0·279 |
TLR-7 | 1·365 ± 1·171 | 1·872 ± 0·756 | 0·011 |
TLR-8 | 3·658 ± 1·854 | 3·473 ± 1·985 | 0·741 |
TLR-9 | 1·477 ± 1·883 | 2·791 ± 1·914 | 0·007 |
IFN-α | 0·037 ± 0·045 | 0·069 ± 0·059 | 0·033 |
LY6E | 0·094 ± 0·044 | 0·343 ± 0·163 | 0·0000067 |
P-value was estimated by Mann–Whitney U-test. LY6E, lymphocyte antigen 6 complex, locus E; IFN, interferon.